| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1532-5415.1993.TB06454.X |
| P698 | PubMed publication ID | 8409152 |
| P50 | author | Steven L. Phillips | Q63575401 |
| P2093 | author name string | Branaman-Phillips J | |
| P2860 | cites work | Risk factors for nosocomial pneumonia in the elderly | Q37826386 |
| Antimicrobial therapy for the elderly patient | Q38006505 | ||
| A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections | Q40743989 | ||
| The atypical presentation of infection in old age. | Q40795459 | ||
| Differences in Etiology of Pneumonias in Nursing Home and Community Patients | Q40946388 | ||
| Bacterial pneumonia in the elderly | Q43509806 | ||
| Nosocomial infections in long-term facilities | Q43634510 | ||
| Twelve-month surveillance of infections in institutionalized elderly men. | Q44053216 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pneumonia | Q12192 |
| ceftriaxone | Q421713 | ||
| P304 | page(s) | 1071-1074 | |
| P577 | publication date | 1993-10-01 | |
| P1433 | published in | Journal of the American Geriatrics Society | Q6296094 |
| P1476 | title | The use of intramuscular cefoperazone versus intramuscular ceftriaxone in patients with nursing home-acquired pneumonia | |
| P478 | volume | 41 |
| Q44261936 | A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia |
| Q43933899 | A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults |
| Q34316513 | A systematic mapping review of randomized controlled trials (RCTs) in care homes |
| Q33749705 | Antibiotic therapy for community-acquired pneumonia |
| Q34629490 | Antibiotic treatment and survival of nursing home patients with lower respiratory tract infection: a cross-national analysis. |
| Q34021161 | Antimicrobial use in long-term-care facilities. SHEA Long-Term-Care Committee |
| Q40676310 | Approach to fever and infection in the nursing home |
| Q77434756 | Community-acquired pneumonia: epidemiology, etiology, treatment |
| Q36140683 | Epidemiology of community- and nursing home-acquired pneumonia in older adults |
| Q44700590 | Ertapenem therapy for community-acquired pneumonia in the elderly |
| Q35368713 | Infections and antibiotic resistance in nursing homes |
| Q41097577 | Management of pneumonia in elderly people |
| Q35673808 | New developments in antibacterial choice for lower respiratory tract infections in elderly patients |
| Q33709485 | Nursing home-acquired pneumonia |
| Q41232554 | Nursing home-acquired pneumonia. Treatment options |
| Q51753731 | Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumonia. |
| Q74798758 | Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications |
| Q28288350 | Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention |
| Q34579293 | Pneumonia in the long-term-care facility |
| Q40662713 | Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society |
| Q51987842 | What is the quality of the reporting of research ethics in publications of nursing home research? |
| Q71895336 | Whether to transfer? Factors associated with hospitalization and outcome of elderly long-term care patients with pneumonia |
Search more.